Literature DB >> 24487476

Cervical cancer screening in Ghana, west Africa: prevalence of abnormal cytology and challenges for expanding screening.

Kathryn S Handlogten1, Rochelle J Molitor, Lindsey E Roeker, Nirmala P Narla, Maria J Bachman, Solomon Quayson, Osei Owusu-Afriyie, Ernest Adjei, Frank Ankobea, Amy Clayton, Lewis Roberts, Kathy MacLaughlin, Daniel Ansong.   

Abstract

Aims were to assess the prevalence of Papanicolaou (Pap) abnormalities found with cervical cancer screening in Agogo and Nkawie, communities in the Ashanti region of Ghana, and compare the correlation between Pap readings performed at the Komfo Anokye Teaching Hospital in Kumasi, Ghana, and at the Mayo Clinic cytology laboratory in Rochester, MN. Demographic data was collected and Pap tests were performed on women recruited for screening in the communities of Agogo (n=119) and Nkawie (n=255). The Pap tests were assessed by pathology laboratory staff at Komfo Anokye Teaching Hospital and Mayo Clinic. There was a significant difference in prevalence of abnormal cytology between the sites with a rate of 12.6% in Agogo and 3.5% in Nkawie (P=0.016). Demographic differences were noted in education level (P<0.001), occupation (P<0.001), religion (P=0.002), and marital status (P<0.001). The Cohen correlation coefficient between the two pathology departments interpreting samples was 0.185, which indicates a significant degree of discordance (P<0.001). Currently Ghana does not have a national cervical cancer screening program. Identifying higher risk communities and patients as a priority for screening may be useful with limited resources. Accurate identification of Pap abnormalities is necessary to implement an effective screening program.

Entities:  

Mesh:

Year:  2014        PMID: 24487476     DOI: 10.1097/PGP.0b013e318298a9e6

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  10 in total

1.  Awareness and Beliefs About Cervical Cancer, the HPV Vaccine, and Cervical Cancer Screening Among Ghanaian Women with Diverse Education Levels.

Authors:  Michelle S Williams; Ernest Kenu; Augustine Adanu; Ruth Angela Yalley; Nicholas Kwaku Lawoe; Akpanga Seyram Dotse; Rita Fosuah Adu; Kevin Fontaine
Journal:  J Cancer Educ       Date:  2019-10       Impact factor: 2.037

2.  Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women.

Authors:  Dorcas Obiri-Yeboah; Patrick K Akakpo; Mohamed Mutocheluh; Emmanuel Adjei-Danso; Gloria Allornuvor; Daniel Amoako-Sakyi; Yaw Adu-Sarkodie; Philippe Mayaud
Journal:  BMC Cancer       Date:  2017-10-16       Impact factor: 4.430

3.  Prevalence of cervical cancer and pre-cancerous lesions among unscreened Women in Kumasi, Ghana.

Authors:  Emmanuel Timmy Donkoh; Francis Agyemang-Yeboah; Richard Harry Asmah; Edwin K Wiredu
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

4.  Acceptability and implementation challenges of smartphone-based training of community health nurses for visual inspection with acetic acid in Ghana: mHealth and cervical cancer screening.

Authors:  Ramin Asgary; Helen Cole; Philip Adongo; Ada Nwameme; Ernest Maya; Amanda Adu-Amankwah; Hannah Barnett; Richard Adanu
Journal:  BMJ Open       Date:  2019-07-16       Impact factor: 2.692

Review 5.  Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective.

Authors:  Sarah Finocchario-Kessler; Catherine Wexler; May Maloba; Natabhona Mabachi; Florence Ndikum-Moffor; Elizabeth Bukusi
Journal:  BMC Womens Health       Date:  2016-06-04       Impact factor: 2.809

6.  Factors Affecting Uptake of Cervical Cancer Screening Among African Women in Klang Valley, Malaysia

Authors:  Cecilia Chinemerem Nwabichie; Rosliza Abdul Manaf; Suriani Binti Ismail
Journal:  Asian Pac J Cancer Prev       Date:  2018-03-27

7.  Factors associated with late presentation of cervical cancer cases at a district hospital: a retrospective study.

Authors:  Priscilla Dunyo; Kofi Effah; Emilia Asuquo Udofia
Journal:  BMC Public Health       Date:  2018-10-03       Impact factor: 3.295

8.  Self-Collected Specimens Revealed a Higher Vaccine- and Non-Vaccine-Type Human Papillomavirus Prevalences in a Cross-Sectional Study in Akuse.

Authors:  Adolf K Awua; Alberto Severini; Edwin K Wiredu; Edwin A Afari; Vanessa A Zubach; Richard M K Adanu
Journal:  Adv Prev Med       Date:  2020-01-22

9.  Evaluating smartphone strategies for reliability, reproducibility, and quality of VIA for cervical cancer screening in the Shiselweni region of Eswatini: A cohort study.

Authors:  Ramin Asgary; Nelly Staderini; Simangele Mthethwa-Hleta; Paola Andrea Lopez Saavedra; Linda Garcia Abrego; Barbara Rusch; Tombo Marie Luce; Lorraine Rusike Pasipamire; Mgcineni Ndlangamandla; Elena Beideck; Bernhard Kerschberger
Journal:  PLoS Med       Date:  2020-11-19       Impact factor: 11.069

10.  Female health-care providers' advocacy of self-sampling after participating in a workplace program for cervical cancer screening in Ghana: a mixed-methods study.

Authors:  Anna-Lisa Behnke; Amrei Krings; Comfort Mawusi Wormenor; Priscilla Dunyo; Andreas M Kaufmann; Joseph Emmanuel Amuah
Journal:  Glob Health Action       Date:  2020-12-31       Impact factor: 2.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.